“When our vaccine makers make vaccines for our children, the nutritional status, the genetic background-are taken into account to find out whether the vaccine will be fully effective. The NITI Aayog member said in a press conference on Friday. Stating that every country has its own parameter for approval of vaccinations for its population despite the world sharing a common scientific framework for approval, Paul clarified that India also follows its own regulatory process for approval that is tailor-made for its population. USFDA’s decision to ask Bharat Biotech to apply for a full BLA has been welcomed by the NITI Aayog memberĭenial of emergency use authorisation to Bharat Biotech made Covaxin by the United States Food and Drug Administration’s (USFDA) has no bearing on the policies in India said NITI Aayog member (Health) Dr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |